A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)
Trial details
- Registry ID
- NCT06990984
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)NCT06990984 | Thiogenesis Therapeutics, Inc. | Phase 2 | Not yet recruiting | 2027-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |